These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24272446)

  • 1. Use of microRNAs in personalized medicine.
    Avci CB; Baran Y
    Methods Mol Biol; 2014; 1107():311-25. PubMed ID: 24272446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA pharmacogenomics: the new frontier for personalized medicine in cancer?
    Dreussi E; Biason P; Toffoli G; Cecchin E
    Pharmacogenomics; 2012 Nov; 13(14):1635-50. PubMed ID: 23148639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics and personalized medicine: the future for drug prescribing.
    Mitri Z; Esmerian MO; Simaan JA; Sabra R; Zgheib NK
    J Med Liban; 2010; 58(2):101-4. PubMed ID: 20549897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
    Xia H; Hui KM
    Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice.
    Giovannetti E; Erozenci A; Smit J; Danesi R; Peters GJ
    Crit Rev Oncol Hematol; 2012 Feb; 81(2):103-22. PubMed ID: 21546262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The paradigm of personalized therapy in oncology.
    Gasparini G; Longo R
    Expert Opin Ther Targets; 2012 Mar; 16 Suppl 1():S7-16. PubMed ID: 22073968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical practice on the horizon: personalized medicine.
    Chadwell K
    Clin Nurse Spec; 2013; 27(1):36-43. PubMed ID: 23222027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
    Glinsky GV
    J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of microRNAs in prostate cancer: implications for personalized medicine.
    Gandellini P; Folini M; Zaffaroni N
    Discov Med; 2010 Mar; 9(46):212-8. PubMed ID: 20350487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA pharmacogenomics: post-transcriptional regulation of drug response.
    Rukov JL; Shomron N
    Trends Mol Med; 2011 Aug; 17(8):412-23. PubMed ID: 21652264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MicroRNAs in bipolar disorder: diagnostic and therapeutic applications].
    Suárez-Gómez M; Alejandre-Durán E; Ruiz-Rubio M
    Rev Neurol; 2011 Jul; 53(2):91-8. PubMed ID: 21720979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs as oncogenes.
    Hammond SM
    Curr Opin Genet Dev; 2006 Feb; 16(1):4-9. PubMed ID: 16361094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current status and future potential of personalized diagnostics: Streamlining a customized process.
    Richmond TD
    Biotechnol Annu Rev; 2008; 14():411-22. PubMed ID: 18606372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs from biology to future pharmacotherapy: regulation of cytochrome P450s and nuclear receptors.
    Nakajima M; Yokoi T
    Pharmacol Ther; 2011 Sep; 131(3):330-7. PubMed ID: 21565218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized medicine and rescuing "unsafe" drugs with pharmacogenomics: a regulatory perspective.
    Avery M
    Food Drug Law J; 2010; 65(1):37-65, i-ii. PubMed ID: 24475534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA as a new factor in lung and esophageal cancer.
    Billeter AT; Barnett RE; Druen D; Polk HC; van Berkel VH
    Semin Thorac Cardiovasc Surg; 2012; 24(3):155-65. PubMed ID: 23200070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs and future therapeutic applications in cancer.
    Casalini P; Iorio MV
    J BUON; 2009 Sep; 14 Suppl 1():S17-22. PubMed ID: 19785062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management.
    Lowery AJ; Miller N; McNeill RE; Kerin MJ
    Clin Cancer Res; 2008 Jan; 14(2):360-5. PubMed ID: 18223209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized medicine: changing the paradigm of drug development.
    Couch RD; Mott BT
    Methods Mol Biol; 2012; 823():367-78. PubMed ID: 22081358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.